- Home
- ORGO vs ASA Comparison
ORGO vs ASA Comparison
Compare ORGO & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- ASA
- Stock Information
- Founded
- ORGO 1985
- ASA 1958
- Country
- ORGO United States
- ASA United States
- Employees
- ORGO N/A
- ASA N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- ASA Precious Metals
- Sector
- ORGO Health Care
- ASA Industrials
- Exchange
- ORGO Nasdaq
- ASA Nasdaq
- Market Cap
- ORGO 620.3M
- ASA 697.1M
- IPO Year
- ORGO N/A
- ASA N/A
- Fundamental
- Price
- ORGO $4.90
- ASA $41.43
- Analyst Decision
- ORGO Buy
- ASA
- Analyst Count
- ORGO 2
- ASA 0
- Target Price
- ORGO $7.50
- ASA N/A
- AVG Volume (30 Days)
- ORGO 761.1K
- ASA 155.2K
- Earning Date
- ORGO 11-11-2025
- ASA 09-26-2025
- Dividend Yield
- ORGO N/A
- ASA 0.14%
- EPS Growth
- ORGO N/A
- ASA 331.75
- EPS
- ORGO N/A
- ASA 14.01
- Revenue
- ORGO $429,531,000.00
- ASA $3,923,667.00
- Revenue This Year
- ORGO $2.57
- ASA N/A
- Revenue Next Year
- ORGO $9.80
- ASA N/A
- P/E Ratio
- ORGO N/A
- ASA $2.96
- Revenue Growth
- ORGO N/A
- ASA 66.52
- 52 Week Low
- ORGO $2.48
- ASA $19.25
- 52 Week High
- ORGO $6.71
- ASA $41.50
- Technical
- Relative Strength Index (RSI)
- ORGO 52.77
- ASA 76.49
- Support Level
- ORGO $4.75
- ASA $39.81
- Resistance Level
- ORGO $5.10
- ASA $41.50
- Average True Range (ATR)
- ORGO 0.21
- ASA 0.87
- MACD
- ORGO -0.02
- ASA 0.26
- Stochastic Oscillator
- ORGO 39.39
- ASA 99.05
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.